Changes to Articles of Incorporation, Bylaws, or Fiscal Year

Business Context and Reporting Period

This Form 8-K is a current report filed by Ekso Bionics Holdings, Inc. (not Chronoscale Holdings Corp) on December 21, 2017. The filing documents corporate governance actions taken at a Special Meeting of Stockholders held on the same date. The company is incorporated in Nevada and identifies as an emerging growth company.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate structural amendments and shareholder voting results rather than financial performance.

Material Changes

  • Authorized Share Increase: The Company amended its Certificate of Incorporation to increase the authorized number of common stock shares from 71,428,571 to 141,428,571.
  • Equity Plan Expansion: The Company amended its 2014 Equity Incentive Plan to increase the maximum number of shares available for grant from 3,714,285 to 4,714,285.

Shareholder Voting Results

Stockholders voted on three proposals at the Special Meeting:

  • Proposal 1 (Charter Amendment): Approved with 37,714,117 votes For, 7,761,992 Against, and 668,592 Abstain.
  • Proposal 2 (Equity Plan Amendment): Approved with 25,205,072 votes For, 2,955,074 Against, and 356,145 Abstain. Notably, there were 17,628,410 Broker Non-Votes.
  • Proposal 3 (Adjournment): Approved with 38,410,089 votes For, 7,288,278 Against, and 446,334 Abstain.

Outlook, Risks, and Contingencies

The filing does not contain management commentary on future outlook, specific risks, or contingencies beyond the procedural necessity of the adjournment proposal to solicit additional proxies if necessary.

Investor Verification Checklist

  • Verify the exact number of authorized shares post-amendment (141,428,571) to assess potential dilution impact.
  • Review the updated 2014 Equity Incentive Plan to understand the new pool of shares available for employee compensation.
  • Confirm the high volume of Broker Non-Votes (17.6 million) on Proposal 2 and its implications for future proxy solicitations.
  • Check subsequent filings for the actual issuance of shares from the newly authorized pool.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.